The first insights into how the PGRN is expressed in GBM were provided by Liau et al., which methodically covered the isolation of tumour-specific antibodies and their evaluation in multiple different human gliomas via cDNA microarray hybridization [26]. The gene discussed is GRN; the disease is central nervous system cancer.